因此大型药企要求“激励措施”才愿开展新抗生素的研发，比方说延长专利期限或减税；另外一种办法是为新药开出天文数字的价格。
So Big Pharma is seeking “incentives” to pursue research and development of new antibiotics, such as extended patents or tax breaks; the alternative would be to charge astronomical prices for new drugs.